Topics: Director Confidence Index

report

Director Confidence Index – August 2021

Director optimism continued to slide in August and into the early days of September due to a growing list of concerns.

report

Director Confidence Index – July 2021

July’s Director Confidence Index shows optimism on the decline for the third consecutive month amid board members due to concerns over inflation and the possibility of further COVID-related restrictions.

report

Director Confidence Index – June 2021

Our gauge of U.S. public company board member confidence is now just 3 percent above where it was last fall, before Covid-19 vaccines were released.

report

Director Confidence Index – May 2021

U.S. public company board members’ optimism dropped at the end of Q2 amid fears that inflation will hamper growth in 2022.

report

Director Confidence Index – April 2021

U.S. public company board members’ optimism heading into the spring is increasingly tempered by worries over new taxes and regulations.

report

Director Confidence Index – March 2021

U.S. public company board members are increasingly confident about the future for business, betting on low interest rates and the unleashing of consumer demand following a successful vaccine rollout.

report

Director Confidence Index – February 2021

Vaccines, consumer behavior and pent-up demand fuel optimism in America’s boardrooms.

report

Director Confidence Index – January 2021

Our latest poll of U.S. public company board members shows increased optimism about business in 2021, betting on a successful vaccine rollout and a return to political stability—although many remain cautious over the potential for increased taxes and new regulations.

report

Director Confidence Index – December 2020

Our December Director Confidence Index shows half of public company board members now forecast a return to pre-crisis profitability in 2021; Support for board diversity mandates growing.

report

Director Confidence Index – October 2020

The inaugural Director Confidence Index, conducted in collaboration between Corporate Board Member and Diligent Institute prior to the public release of the President’s Covid-19 diagnosis, finds cautious optimism for the future of the U.S. economy—with caveats.

Funded by Diligent Corporation

Learn More Here